Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000922423-04-001671
Filing Date
2004-10-08
Accepted
2004-10-08 13:46:26
Documents
1
Period of Report
2004-07-29

Document Format Files

Seq Description Document Type Size
1 kl09060_ex.html 3  
1 kl09060_ex.xml 3 2158
  Complete submission text file 0000922423-04-001671.txt   4044
Mailing Address 420 LEXINGTON AVE SUITE 601 NEW YORK NY 10170
Business Address 420 LEXINGTON AVE SUITE 601 NEW YORK NY 10170 2126729100
SIGA TECHNOLOGIES INC (Issuer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170
Business Address 212-672-9100
Odden John (Reporting) CIK: 0001303263 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23047 | Film No.: 041071859